X4 Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. The firm is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
CEOPaula S. Ragan, PhD
CEOPaula S. Ragan, PhD
Employees143
Employees143
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2010
Founded2010
Employees143
Employees143
XFOR Key Statistics
Market cap323.52M
Market cap323.52M
Price-Earnings ratio-0.37
Price-Earnings ratio-0.37
Dividend yield—
Dividend yield—
Average volume603.73K
Average volume603.73K
High today$3.73
High today$3.73
Low today$3.61
Low today$3.61
Open price$3.62
Open price$3.62
Volume126.28K
Volume126.28K
52 Week high$26.83
52 Week high$26.83
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
With a market cap of 323.52M, X4 Pharmaceuticals(XFOR) trades at $3.70. The stock has a price-to-earnings ratio of -0.37.
During the trading session on 2025-11-14, X4 Pharmaceuticals(XFOR) shares reached a daily high of $3.73 and a low of $3.61. At a current price of $3.70, the stock is +2.5% higher than the low and still -0.8% under the high.
Trading volume for X4 Pharmaceuticals(XFOR) stock has reached 126.28K, versus its average volume of 603.73K.
The stock's 52-week range extends from a low of $1.35 to a high of $26.83.
The stock's 52-week range extends from a low of $1.35 to a high of $26.83.
People also own
Based on the portfolios of people who own XFOR. This list is generated using Robinhood data, and it’s not a recommendation.